Cellectis (CLLS) FCF Margin (2015 - 2026)
Cellectis (CLLS) posted quarterly FCF Margin of 262.16% for Q1 2026, down 10482.0% year-over-year from N/an in Q1 2025, and down 128.32% quarter-over-quarter from 114.82% in Q4 2025.
Cellectis (CLLS) FCF Margin (2015 - 2026) Analysis & Trends
Cellectis' FCF Margin history runs 12 years deep, the most recent figure standing at 262.16% for Q1 2026.
- In Q1 2026, FCF Margin fell 10482.0% year-over-year to 262.16%; the TTM figure through Mar 2026 stood at 57.03% (down 10534.0% YoY), while the FY2025 annual figure was 57.25%, down 9871.0% from the prior year.
- FCF Margin for Q1 2026 stood at 262.16%, down from 114.82% in the prior quarter.
- The five-year high for FCF Margin was 660.19% in Q2 2024, with the low at 20225.18% in Q1 2023.
- The 5-year median for FCF Margin is 157.34% (2025), against an average of 3542.25%.
- The sharpest annual moves came in 2023 and 2024: FCF Margin plunged 1806386 bps in 2023, then surged 1971509 bps in 2024.
- Cellectis' FCF Margin stood at 35.2% in 2022, then soared by 1333 bps to 433.98% in 2023, then plunged by 105 bps to 22.83% in 2024, then tumbled by 403 bps to 114.82% in 2025, then sank by 128 bps to 262.16% in 2026.
- Business Quant data shows CLLS's FCF Margin at 262.16% in Q1 2026, 114.82% in Q4 2025, and 1.11% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | -262.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -262.16% |
| Dec 31, 2025 | -114.82% |
| Sep 30, 2025 | -1.11% |
| Jun 30, 2025 | -59.82% |
| Mar 31, 2025 | -157.34% |
| Dec 31, 2024 | -22.83% |
| Sep 30, 2024 | -31.19% |
| Jun 30, 2024 | 660.19% |
| Mar 31, 2024 | -510.09% |
| Dec 31, 2023 | 433.98% |
| Sep 30, 2023 | -10,825.81% |
| Jun 30, 2023 | -10,546.63% |
| Mar 31, 2023 | -20,225.18% |
| Dec 31, 2022 | -35.20% |
| Sep 30, 2022 | -14,625.71% |
| Jun 30, 2022 | -1,733.28% |
| Mar 31, 2022 | -2,161.32% |
| Dec 31, 2021 | -564.01% |
| Sep 30, 2021 | -310.55% |
| Jun 30, 2021 | -59.73% |